MEK2 Gene Mutation
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer (NCT05054374) | Memorial Sloan Kettering Cancer Center | 2021-09-14 |
| A Basket Trial of an ERK1/2 Inhibitor (LY3214996) in Combination With Abemaciclib. (NCT04534283) | Anita Turk | 2020-10-05 |
Track MEK2 Gene Mutation automatically
Every clearance here is in the API, with alerts when new ones post.